David Hering is recorded as Board Member at Invivyd, Inc. (IVVD) since July 5, 2022. Invivyd, Inc. reported in an 8-K filed April 12, 2024 that David Hering resigned as Director. Invivyd, Inc. reported in an 8-K filed February 9, 2024 that David Hering was appointed Chief Executive Officer, effective July 1, 2022. Invivyd, Inc. reported in an 8-K filed July 5, 2022 that David Hering was appointed Class III director, effective July 5, 2022. Equibles holds 4 filed executive changes naming David Hering; each is listed under recent activity with its source filing. The proxy statement of Invivyd, Inc. reports total compensation of $1,243,417 for David Hering in fiscal 2024, including a base salary of $227,199. Disclosed compensation is on record for 4 fiscal years. David Hering has spoken on 2 earnings calls across 1 company, most recently for Invivyd, Inc. on May 11, 2023. Invivyd, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Invivyd, Inc. includes Jeremy Gowler (CEO and COO), Marc Elia (CEO and Board Member), William Duke, Jr. (CEO) and 7 others.
“In connection with Mr. Hering ceasing to serve as Chief Executive Officer, Mr. Hering has also resigned from the Board pursuant to the terms of the Hering Employment Agreement.”
Invivyd, Inc. Form 8-K, filed April 12, 2024
· Read the filing
“In July 2022, David Hering, M.B.A. was appointed as the Company's Chief Executive Officer.”
Invivyd, Inc. Form 8-K, filed February 9, 2024
· Read the filing
David Hering on recent calls
“Thank you for joining us today on our quarterly update call, and thank you for your continued support of Invivyd.”
“It happens to be our first quarterly earnings call as a public company and my first call as Chief Executive Officer, so our agenda will be just a little different than it may be going forward.”
